Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GB SCIENCES, INC.

(GBLX)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about GB SCIENCES, INC.
09/14Gb Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndr..
GL
09/14GB Sciences Achieves Positive Proof-of-Concept Results for Their Cytokine Release Syndr..
CI
09/09Gb Sciences Presenting COVID-Related Cytokine Release Syndrome Results at H.C. Wainwrig..
GL
07/06Gb Sciences, Inc. Reports Earnings Results for the Full Year Ended March 31, 2021
CI
06/16GB SCIENCES : Resignation and Appointment of Certain Officers (Form 8-K)
PU
06/16GB Sciences, Inc. Announces Executive Changes
CI
06/14GB SCIENCES : Appointment of Certain Officers (Form 8-K)
PU
06/14GB Sciences, Inc. Announces Board Appointments
CI
03/24AJE Management, LLC cancelled the acquisition of GB Sciences Las Vegas, LLC and GB Scie..
CI
02/16Gb Sciences, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 202..
CI
2020Wellcana Plus, LLC completed the acqusition of 50.01% interest in GB Sciences Louisiana..
CI
2020GB Sciences, Inc. Announces Resignation of Leslie Bocskor as A Member of the Board of D..
CI
2020Gb Sciences, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2..
CI
2020Gb Sciences, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020
CI
2020AJE Management, LLC entered into a membership interest purchase agreement to acquire GB..
CI
2020Gb Sciences, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 201..
CI
2019GB SCIENCES : Announces Outstanding Results from Preclinical Study of Its Parkinson's Dise..
AQ
2019GB Sciences, Inc. Announces Outstanding Results from Preclinical Study of its Parkinson..
CI
2019Gb Sciences, Inc. Announces Resignation of Shane Terry as a Member of the Board
CI
2019Gb Sciences, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2..
CI
2019Gb Sciences, Inc. Withdraws Offer of Appointment to Darin Carpenter as Executive Vice P..
CI
2019Bb Sciences, Inc. Appoints Edmond A. Defrank as Member of the Board
CI
2019GB Sciences, Inc. announced that it has received $0.24 million in funding
CI
2019GB Sciences, Inc. announced that it expects to receive $0.24 million in funding
CI
2019GB Sciences, Inc. announced that it has received $2.93197 million in funding
CI
2019GB Sciences, Inc. announced that it has received $7.2 million in funding
CI
2019GB Sciences, Inc. Announces Management Changes
CI
2019GB Sciences, Inc. Appoints Darin Carpenter as Executive Vice President for Operations a..
CI
2019Wellcana Plus, LLC signed a term sheet to acquire 50.01% interest in GB Sciences Louisi..
CI
2019Gb Sciences, Inc. Reports Earnings Results for the Full Year Ended March 31, 2019
CI
2019GB Sciences, Inc. Obtains Exclusive License for Patented Oral Thin Film Technology Cont..
CI
2019GB Sciences, Inc. Prepares to Triple Production Capabilities in its Las Vegas Facility
CI
2019GB Sciences, Inc. announced that it has received $2.515 million in funding from Iliad M..
CI
2019GB Sciences, Inc. Receives All Approvals and Announces the Opening of the Full Tissue P..
CI
2019GB Sciences, Inc. Announces the LSU Agricultural Center Received Confirmation from the ..
CI
2019GB Sciences, Inc. Launches Global Expansion in Canada with GBS Global Biopharma, Inc
CI
2019Gb Sciences, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 201..
CI
2018GB Sciences And Louisiana State University Agricultural Center Enter a Joint Research a..
CI
2018GB Sciences, Inc. announced a financing transaction
CI
2018GB Sciences, Inc. Signs Binding Letter of Intent with 4EVERGRN, LLC
CI
2018GB SCIENCES : Meredith Patterson, GB Sciences' Brain Nurse, Examines the Workings of CBD
PR
2018GB Sciences, Inc. announced that it has received $5 million in funding
CI
2018GB Sciences, Inc. Initiates a New Project with the Department of Pharmacognosy and Natu..
CI
2018GB Sciences, Inc.'s Drug Development Program Benefits from Establishment of Clear Pathw..
CI
2018GB Sciences Receives a Recreational Production License for the Manufacture of Oils, Edi..
CI
2018GB Sciences, Inc. Announces Management Changes
CI
2018GB Sciences, Inc. announced that it has received $4.1205 million in funding
CI
2018GB Sciences, Inc. and Louisiana State University Agricultural Center Begins Cultivation..
CI
2018GB Sciences, Inc Announces Earnings Results for the First Quarter Ended June 30, 2018
CI
2018GB Sciences, Inc. announced that it expects to receive $5 million in funding
CI
2018GB Sciences, Inc. Partners with the Colorado Hemp Project to Cultivate and Extract Full..
CI
2018GB SCIENCES : One of Ten Companies Named in Important New Canadian Research Publication
PR
2018GB Sciences, Inc. Files Patents for Heart Disease and Chronic, Immunological, and Neuro..
CI
2018GB Sciences, Inc. cancelled the acquisition of NevadaPURE, LLC.
CI
2018GB Sciences, Inc. Plans to File an Exploratory IND and Perform a Phase 0 Clinical Trial..
CI
2018GB Sciences Appoints John B. Davis as Executive VP and General Counsel and as President..
CI
2018GB Sciences, Inc. entered into a letter of intent to acquire NevadaPURE, LLC for $33 mi..
CI
2018GB Sciences, Inc. announced that it has received $2 million in funding
CI
2018GB Sciences, Inc. Announces New Agreement with the Colorado Hemp Project
CI
2018Cesar Cordero-Kruger acquired an additional 17% stake in GB Sciences Puerto Rico, LLC f..
CI
2018GB Sciences, Inc. Announces Appointment of Zoltan Mari to Scientific Advisory Board
CI
2018GB Sciences, Inc. announced that it expects to receive $7.2 million in funding
CI
2017GB Sciences, Inc. announced that it has received $3.895 million in funding
CI
2017GB Sciences, Inc. Reports Sales Results for the Month of October 2017; Provides Sales G..
CI
2017Gb Sciences, Inc. Appoints Kevin Kuethe as COO
CI
2017GB Sciences, Inc. Partners with Cura Cannabis Solutions and Enters the Lucrative Cannab..
CI
2017GB Sciences, Inc. Reports Unaudited Sales Results for the Quarter Ended September 30, 2..
CI
2017GB Sciences, Inc. Obtains Exclusive Worldwide License on A Time-Released Cannabinoid Fo..
CI
2017GB Sciences, Inc. Announces Nanotechnology Research Collaboration with Universidad de S..
CI
2017GB SCIENCES : Initiates Cannabis-based Therapy Clinical Trials Consulting Services Agreeme..
PR
2017GB Sciences Initiates Cannabis-based Therapy Clinical Trials Consulting Services Agreem..
CI
2017GB Sciences, Inc. announced a financing transaction
CI
2017GB SCIENCES : Sells First Cannabis Harvest and Officially Enters Revenue Mode
PR
2017GB Sciences, Inc. Wins Louisiana State University Bid to Act as LSU Agricultural Center..
CI
2017LSU AgCenter Selects GB Sciences, Inc. for Medical Marijuana Program
CI
1  2Next